# BRUKER CORP

Summary updated: 2026-10-04T09:32:54.58149Z
Canonical: https://finbar.com/research/companies/bruker-corp

## Overview

Bruker Corporation develops and manufactures scientific instruments and analytical and diagnostic solutions used to investigate biological systems and materials at molecular, cellular and microscopic levels. Its products span magnetic resonance, mass spectrometry, chromatography, X-ray systems, microscopy, metrology, spectroscopy, automation and software, serving life-science, applied and industrial markets. [1](https://app.finbar.com/go?id=P147162001)[2](https://www.bruker.com/en/about/our-business-groups.html)

Bruker’s business is organized into four segments: BSI BioSpin, BSI CALID, BSI NANO and Bruker Energy & Supercon Technologies (BEST). The company states its mission as “We innovate, shape, and create a better world.” [1](https://app.finbar.com/go?id=P147162001)[3](https://www.bruker.com/en/careers/our-culture.html)

Headquartered in Billerica, Massachusetts, Bruker has research and manufacturing centers in North America, Europe and Asia, with commercial offices worldwide. The company reports more than 11,000 employees and over 90 locations globally. Revenue was approximately $3.44 billion in fiscal 2025. [1](https://app.finbar.com/go?id=P147162001)[4](https://www.bruker.com/en/about.html)[5](https://app.finbar.com/go?id=T2170895)
[1](https://app.finbar.com/go?id=P147162001)[5](https://app.finbar.com/go?id=T2170895)[2](https://www.bruker.com/en/about/our-business-groups.html)[3](https://www.bruker.com/en/careers/our-culture.html)[4](https://www.bruker.com/en/about.html)

## Products & services

Bruker’s products include magnetic-resonance instruments, mass spectrometers, spectroscopy and chromatography systems, molecular-diagnostic assays, X-ray and microscopy tools, metrology systems, and superconducting wire. Its technology platforms include NMR, EPR, MRI, mass spectrometry, X-ray analysis, microscopy, metrology and molecular spectroscopy. [6](https://app.finbar.com/go?id=P15402521)

Its BioSpin portfolio includes benchtop to ultra-high-field NMR and EPR systems, as well as preclinical MRI, PET, SPECT, CT and MPI imaging systems. CALID products include MALDI-TOF systems such as Biotyper for microbial identification; ESI-TOF and timsTOF, MRMS and ion-mobility platforms for applications including proteomics, metabolomics and drug discovery; GC-MS, LC-MS and DART-MS; and FT-IR, NIR and Raman spectroscopy. Molecular-diagnostics products include FluoroType and LiquidArray PCR assays, plus InGenius and BeGenius automated sample-to-answer PCR systems. [7](https://app.finbar.com/go?id=P47282585)[8](https://app.finbar.com/go?id=T3047566)[9](https://app.finbar.com/go?id=T2700175)[10](https://app.finbar.com/go?id=T4368231)[11](https://app.finbar.com/go?id=P104841795)[12](https://app.finbar.com/go?id=P104730507)[13](https://app.finbar.com/go?id=P62407799)

Materials-analysis products include XRF, µXRF, TXRF, XRD, µCT/X-ray microscopy and optical emission spectroscopy, alongside electron-microscopy tools such as STEM, EDS and EBSD. The portfolio also includes AFM and optical or stylus metrology. Bruker’s spatial-biology and microscopy offerings include CosMx, GeoMx, nCounter, CellScape, PaintScape, and multiphoton, confocal, head-mounted, super-resolution and light-sheet systems. Its superconducting-wire products include NbTi for clinical MRI/NMR and Nb₃Sn for high-field NMR, high-energy physics and fusion research. [14](https://app.finbar.com/go?id=P104625990)[15](https://app.finbar.com/go?id=P117516592)[16](https://app.finbar.com/go?id=P91910464)[17](https://app.finbar.com/go?id=T7073726)[18](https://app.finbar.com/go?id=P75564445)[19](https://app.finbar.com/go?id=P105805077)[20](https://www.bruker.com/en/products-and-solutions/superconductors.html)

Services include instrument lifecycle support, technical support, maintenance agreements, training, consumables, software and documentation; Bruker also offers portable CBRNE detection systems with related consumables, training and simulators. In FY2025, product revenue was $2,766.4 million (80.5% of total revenue) and service and other revenue was $670.1 million (19.5%). Reported segment revenue shares were CALID 35.2%, NANO 31.6%, BioSpin 25.6% and BEST 7.7%; these are segment shares, not product-family shares. [21](https://app.finbar.com/go?id=P82269804)[13](https://app.finbar.com/go?id=P62407799)[5](https://app.finbar.com/go?id=T2170895)[22](https://app.finbar.com/go?id=T5863036)
[6](https://app.finbar.com/go?id=P15402521)[7](https://app.finbar.com/go?id=P47282585)[8](https://app.finbar.com/go?id=T3047566)[9](https://app.finbar.com/go?id=T2700175)[10](https://app.finbar.com/go?id=T4368231)[11](https://app.finbar.com/go?id=P104841795)[12](https://app.finbar.com/go?id=P104730507)[13](https://app.finbar.com/go?id=P62407799)[14](https://app.finbar.com/go?id=P104625990)[15](https://app.finbar.com/go?id=P117516592)[16](https://app.finbar.com/go?id=P91910464)[17](https://app.finbar.com/go?id=T7073726)[18](https://app.finbar.com/go?id=P75564445)[19](https://app.finbar.com/go?id=P105805077)[21](https://app.finbar.com/go?id=P82269804)[5](https://app.finbar.com/go?id=T2170895)[22](https://app.finbar.com/go?id=T5863036)[20](https://www.bruker.com/en/products-and-solutions/superconductors.html)

## Geographic presence

In FY2025, Bruker reported revenue by customer location of $891.3 million in the United States (25.9% of total), $297.0 million in Germany (8.6%), $950.2 million in Europe excluding Germany (27.7%), $475.8 million in China (13.8%), $552.6 million in Asia Pacific excluding China (16.1%), and $269.6 million in Other (7.9%); total revenue was $3,436.5 million. [23](https://app.finbar.com/go?id=T5789880)[24](https://app.finbar.com/go?id=T3637287) Its FY2025 presentation separately reported BSI revenue mix of 30% Americas, 36% Europe, 30% Asia-Pacific and 4% IMEA. [25](https://app.finbar.com/go?id=P89033585)[26](https://app.finbar.com/go?id=P117653669)

Bruker identifies Billerica, Massachusetts, as its headquarters and says it has more than 11,000 employees across over 90 locations on all continents, with major technical and manufacturing centers in Europe, North America and Southeast Asia. Its service network covers the Americas, Europe, Asia Pacific, and India, Middle East and Africa; the cited company materials do not specify employee counts by region. [4](https://www.bruker.com/en/about.html)[27](https://www.bruker.com/en/careers/working-at-bruker.html)[28](https://www.bruker.com/en/services/service/support.html)
[23](https://app.finbar.com/go?id=T5789880)[24](https://app.finbar.com/go?id=T3637287)[25](https://app.finbar.com/go?id=P89033585)[26](https://app.finbar.com/go?id=P117653669)[4](https://www.bruker.com/en/about.html)[27](https://www.bruker.com/en/careers/working-at-bruker.html)[28](https://www.bruker.com/en/services/service/support.html)

## Business segments

Bruker reports four business segments. For FY2025, approximate shares of consolidated revenue were: BSI BioSpin, 25.6% ($878.8 million), focused on magnetic-resonance and preclinical-imaging instrumentation [22](https://app.finbar.com/go?id=T5863036); BSI CALID, 35.2% ($1,210.2 million), encompassing analytical-instrument businesses including mass spectrometry, as well as microbiology and infection diagnostics [22](https://app.finbar.com/go?id=T5863036)[29](https://app.finbar.com/go?id=P27732875)[9](https://app.finbar.com/go?id=T2700175)[10](https://app.finbar.com/go?id=T4368231); BSI NANO, 31.6% ($1,084.3 million), covering nanotechnology and materials and life-science instrumentation, including X-ray analysis, microscopy and spatial biology [22](https://app.finbar.com/go?id=T5863036)[17](https://app.finbar.com/go?id=T7073726); and BEST (Bruker Energy & Supercon Technologies), 7.7% ($263.2 million) [22](https://app.finbar.com/go?id=T5863036).

The four-segment structure remained in place in the six months ended June 30, 2026. For that period, approximate revenue shares were BSI BioSpin 23.7% ($393.2 million), BSI CALID 37.7% ($626.6 million), BSI NANO 30.5% ($507.3 million), and BEST 8.1% ($134.8 million) [1](https://app.finbar.com/go?id=P147162001)[30](https://app.finbar.com/go?id=T16836964)[31](https://app.finbar.com/go?id=T16836994). Bruker also describes divisions and businesses within the segments; these are not additional reportable segments in the cited disclosures. In April 2026, Bruker Cellular Analysis was merged into the Bruker Spatial Biology division [32](https://app.finbar.com/go?id=P147162092).
[22](https://app.finbar.com/go?id=T5863036)[29](https://app.finbar.com/go?id=P27732875)[9](https://app.finbar.com/go?id=T2700175)[10](https://app.finbar.com/go?id=T4368231)[17](https://app.finbar.com/go?id=T7073726)[1](https://app.finbar.com/go?id=P147162001)[30](https://app.finbar.com/go?id=T16836964)[31](https://app.finbar.com/go?id=T16836994)[32](https://app.finbar.com/go?id=P147162092)

## Company history

Bruker was founded in Karlsruhe, Germany, in 1960 by Günther Laukien and Emil Bruker, initially concentrating on magnetic-resonance instrumentation. Its early milestones included the HFX 90 NMR spectrometer in 1967, a Fourier-transform-only NMR system in 1971, and early Fourier-transform ion-cyclotron-resonance mass spectrometers in 1982. [33](https://www.bruker.com/en/about/history-new.html) [34](https://www.bruker.com/en/about/vision-into-reality.html)

The company broadened beyond its NMR roots by establishing Bruker-Franzen Analytik in 1980 and Bruker Saxonia in 1990, and acquiring Siemens AG’s analytical X-ray division in 1997. Frank H. Laukien became president and CEO in 1991. After a 2000 restructuring, Bruker Daltonics and Bruker AXS were listed on Nasdaq in 2001; the units merged in 2003, followed by a business-unit merger completed in 2008. [33](https://www.bruker.com/en/about/history-new.html) [35](https://ir.bruker.com/corporate-governance/management-team/default.aspx?LanguageId=1)

Bruker introduced its solariX next-generation FTMS platform in 2009 and expanded into micro-CT imaging with its 2012 acquisition of SkyScan and nanoscale microscopy with JPK Instruments in 2018. From 2022 through 2024, acquisitions including Inscopix, PhenomeX, ELITechGroup, NanoString’s business assets, Chemspeed, Dynamic Biosensors, and Nion further broadened its activities in neuroscience, life sciences, diagnostics, laboratory automation, and microscopy. [36](https://ir.bruker.com/press-releases/press-release-details/2009/Bruker-Expands-the-Boundaries-of-Ultra-High-Performance-Mass-Spectrometry-with-the-Introduction-of-solariXTM-the-Next-Generation-FTMS-Platform/default.aspx) [37](https://ir.bruker.com/press-releases/press-release-details/2012/Bruker-Announces-Acquisition-of-SkyScan-a-Leading-Provider-of-Micro-CT-Systems-for-3D-X-Ray-Imaging-in-Materials-Research-and-Preclinical-Studies/default.aspx) [38](https://ir.bruker.com/press-releases/press-release-details/2018/Bruker-Announces-Acquisition-of-JPK-Instruments/default.aspx) [39](https://ir.bruker.com/press-releases/press-release-details/2022/Bruker-Announces-Acquisition-of-Inscopix-for-Neuroscience-Research/default.aspx/1000/default.aspx) [40](https://ir.bruker.com/press-releases/press-release-details/2023/Bruker-Completes-Acquisition-of-PhenomeX/default.aspx) [41](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Completes-Acquisition-of-Molecular-Diagnostics-Innovator-ELITech/default.aspx) [42](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Completes-Asset-Acquisition-of-NanoString-Business/default.aspx) [43](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Announces-Closing-of-Chemspeed-Technologies-AG-Acquisition/default.aspx) [44](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Acquires-Dynamic-Biosensors-a-Pioneer-of-Single-Cell-Interaction-Cytometry-Systems-for-Drug-Discovery/default.aspx) [45](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Acquires-Electron-Microscopy-Company-Nion/default.aspx)
[33](https://www.bruker.com/en/about/history-new.html)[34](https://www.bruker.com/en/about/vision-into-reality.html)[35](https://ir.bruker.com/corporate-governance/management-team/default.aspx?LanguageId=1)[36](https://ir.bruker.com/press-releases/press-release-details/2009/Bruker-Expands-the-Boundaries-of-Ultra-High-Performance-Mass-Spectrometry-with-the-Introduction-of-solariXTM-the-Next-Generation-FTMS-Platform/default.aspx)[37](https://ir.bruker.com/press-releases/press-release-details/2012/Bruker-Announces-Acquisition-of-SkyScan-a-Leading-Provider-of-Micro-CT-Systems-for-3D-X-Ray-Imaging-in-Materials-Research-and-Preclinical-Studies/default.aspx)[38](https://ir.bruker.com/press-releases/press-release-details/2018/Bruker-Announces-Acquisition-of-JPK-Instruments/default.aspx)[39](https://ir.bruker.com/press-releases/press-release-details/2022/Bruker-Announces-Acquisition-of-Inscopix-for-Neuroscience-Research/default.aspx/1000/default.aspx)[40](https://ir.bruker.com/press-releases/press-release-details/2023/Bruker-Completes-Acquisition-of-PhenomeX/default.aspx)[41](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Completes-Acquisition-of-Molecular-Diagnostics-Innovator-ELITech/default.aspx)[42](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Completes-Asset-Acquisition-of-NanoString-Business/default.aspx)[43](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Announces-Closing-of-Chemspeed-Technologies-AG-Acquisition/default.aspx)[44](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Acquires-Dynamic-Biosensors-a-Pioneer-of-Single-Cell-Interaction-Cytometry-Systems-for-Drug-Discovery/default.aspx)[45](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Acquires-Electron-Microscopy-Company-Nion/default.aspx)

## Sources

1. [BRUKER CORP — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P147162001)
2. [www.bruker.com](https://www.bruker.com/en/about/our-business-groups.html)
3. [www.bruker.com](https://www.bruker.com/en/careers/our-culture.html)
4. [www.bruker.com](https://www.bruker.com/en/about.html)
5. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T2170895)
6. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P15402521)
7. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P47282585)
8. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T3047566)
9. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T2700175)
10. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T4368231)
11. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P104841795)
12. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P104730507)
13. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P62407799)
14. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P104625990)
15. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P117516592)
16. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P91910464)
17. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T7073726)
18. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P75564445)
19. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P105805077)
20. [www.bruker.com](https://www.bruker.com/en/products-and-solutions/superconductors.html)
21. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P82269804)
22. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T5863036)
23. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T5789880)
24. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=T3637287)
25. [BRUKER CORP — Presentation (2025 Y), p9](https://app.finbar.com/go?id=P89033585)
26. [BRUKER CORP — Presentation (2025 Y), p9](https://app.finbar.com/go?id=P117653669)
27. [www.bruker.com](https://www.bruker.com/en/careers/working-at-bruker.html)
28. [www.bruker.com](https://www.bruker.com/en/services/service/support.html)
29. [BRUKER CORP — Full financial report (2025 Y)](https://app.finbar.com/go?id=P27732875)
30. [BRUKER CORP — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=T16836964)
31. [BRUKER CORP — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=T16836994)
32. [BRUKER CORP — Full financial report (2026 Q 2)](https://app.finbar.com/go?id=P147162092)
33. [www.bruker.com](https://www.bruker.com/en/about/history-new.html)
34. [www.bruker.com](https://www.bruker.com/en/about/vision-into-reality.html)
35. [ir.bruker.com](https://ir.bruker.com/corporate-governance/management-team/default.aspx?LanguageId=1)
36. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2009/Bruker-Expands-the-Boundaries-of-Ultra-High-Performance-Mass-Spectrometry-with-the-Introduction-of-solariXTM-the-Next-Generation-FTMS-Platform/default.aspx)
37. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2012/Bruker-Announces-Acquisition-of-SkyScan-a-Leading-Provider-of-Micro-CT-Systems-for-3D-X-Ray-Imaging-in-Materials-Research-and-Preclinical-Studies/default.aspx)
38. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2018/Bruker-Announces-Acquisition-of-JPK-Instruments/default.aspx)
39. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2022/Bruker-Announces-Acquisition-of-Inscopix-for-Neuroscience-Research/default.aspx/1000/default.aspx)
40. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2023/Bruker-Completes-Acquisition-of-PhenomeX/default.aspx)
41. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Completes-Acquisition-of-Molecular-Diagnostics-Innovator-ELITech/default.aspx)
42. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Completes-Asset-Acquisition-of-NanoString-Business/default.aspx)
43. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Announces-Closing-of-Chemspeed-Technologies-AG-Acquisition/default.aspx)
44. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Acquires-Dynamic-Biosensors-a-Pioneer-of-Single-Cell-Interaction-Cytometry-Systems-for-Drug-Discovery/default.aspx)
45. [ir.bruker.com](https://ir.bruker.com/press-releases/press-release-details/2024/Bruker-Acquires-Electron-Microscopy-Company-Nion/default.aspx)

AI-generated summary; may contain errors. Not investment advice. Sign up to Finbar to view original document sources and access worldwide fundamental financial data and intelligence.